Bioharvest Sciences Inc stock is traded at $1.32, with a volume of 14,666. It is up +7.32% in the last 24 hours and down -26.67% over the past month. BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. The Company has two operating segments or business units: the Products business unit and the CDMO Services business unit. In identifying these operating segments, management generally follows the Company's service lines representing its main products and services. The Products Business Unit - Nutraceuticals: Research, development, manufacturing, marketing and sales of science-based health and wellness nutraceutical solutions which are manufactured and sold as dietary supplements, functional food and beverages. The CDMO Services Business Unit - comprising a Contract Development and Manufacturing Operation that offers pharmaceuticals, cosmeceuticals, nutraceuticals, and nutritions.
Previous Close:
$1.23
Open:
$1.13
24h Volume:
14,666
Relative Volume:
0.28
Market Cap:
$29.92M
Revenue:
$35.16M
Net Income/Loss:
-$11.44M
P/E Ratio:
-
EPS:
-$0.5961
Net Cash Flow:
-$15.44M
1W Performance:
-19.02%
1M Performance:
-26.67%
6M Performance:
-66.33%
1Y Performance:
-79.08%
1-Day Range:
$1.13$1.48
1-Week Range:
$0.9118$1.64
52-Week Range:
$0.9118$7.20
Bioharvest Sciences Inc Stock (BHST) Company Profile
Market Cap
Revenue
Net Income
Cash Flow
EPS